ControlRad announces first clinical use of its trace radiation reduction technology

Niagara Falls Memorial Medical Center first to integrate newly cleared ControlRad Trace into fluoroscopically guided procedures, improving radiation safety for patients and staff…

ControlRad Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures (FGP), announced the first clinical use of the ControlRad Trace system following its clearance by the U.S. Food and Drug Administration. Andrew Cappuccino, M.D., an orthopedic surgeon specializing in minimally invasive spine surgery, performed the initial procedures at Niagara Falls Memorial Medical Center. […]

The press release said, “The ControlRad Trace system reduces unnecessary radiation, protecting patients and medical staff without compromising image quality in the region of interest and overall workflow. The medical staff draws a region of interest (ROI) on a ControlRad tablet, which in real-time optimizes image quality in the ROI while reducing unnecessary radiation in the periphery.” […]

Click here to view original web page at www.wnypapers.com